US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 29, 2021 (5 years ago)

Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Superpotent and Failed Tablet/Capsule Specifications

What was recalled

Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05

Recalling firm
Aurobindo Pharma USA Inc.
NDC code
57237-221-05
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0450-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other East recalls

See all